178 related articles for article (PubMed ID: 35677516)
1. The Association Between Chronic Plaque Psoriasis and Nonalcoholic Fatty Liver Disease in Indian Patients: Results of a Pilot Study.
Mahajan VK; Chauhan NS; Rana BS; Mehta KS; Hooda S; Chauhan PS; Kukreja A
J Clin Exp Hepatol; 2022; 12(3):785-792. PubMed ID: 35677516
[TBL] [Abstract][Full Text] [Related]
2. Interleukin Levels and Non-Alcoholic Fatty Liver Disease in Chronic Plaque Psoriasis: An Analytical Case Control Study.
Yadav V; Mendiratta V; Agrawal A; Bisherwal K; Singh R; Meena AK
Indian J Dermatol; 2023; 68(4):377-384. PubMed ID: 37822394
[TBL] [Abstract][Full Text] [Related]
3. Correlation Between Psoriasis Severity and Nonalcoholic Fatty Liver Disease Degree Measured Using Controlled Attenuation Parameter.
Gandha N; Wibawa LP; Jacoeb TNA; Sulaiman AS
Psoriasis (Auckl); 2020; 10():39-44. PubMed ID: 33117662
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'IncĂ R; Favero M; Piaserico S; Doria A; Ramonda R
Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
[TBL] [Abstract][Full Text] [Related]
5. FibroScan-AST (FAST) Score for Nonalcoholic Steatohepatitis - Validation in an Indian Cohort.
De A; Keisham A; Mishra S; Mehta M; Verma N; Premkumar M; Taneja S; Das A; Singh V; Duseja A
J Clin Exp Hepatol; 2022; 12(2):440-447. PubMed ID: 35535068
[TBL] [Abstract][Full Text] [Related]
6. The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: a study from South India.
Madanagobalane S; Anandan S
Australas J Dermatol; 2012 Aug; 53(3):190-7. PubMed ID: 22672067
[TBL] [Abstract][Full Text] [Related]
7. Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease.
Abedini R; Salehi M; Lajevardi V; Beygi S
Clin Exp Dermatol; 2015 Oct; 40(7):722-7. PubMed ID: 25958919
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Predictors of Nonalcoholic Fatty Liver Disease in Family Members of Patients With Nonalcoholic Fatty Liver Disease.
Anand A; Singh AA; Elhence A; Vaishnav M; Biswas S; Gunjan D; Gamanagatti SR; Nayak B; Kumar R; Shalimar
J Clin Exp Hepatol; 2022; 12(2):362-371. PubMed ID: 35535086
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of liver stiffness measurement and controlled attenuation parameter using FibroScan
Oeda S; Takahashi H; Imajo K; Seko Y; Ogawa Y; Moriguchi M; Yoneda M; Anzai K; Aishima S; Kage M; Itoh Y; Nakajima A; Eguchi Y
J Gastroenterol; 2020 Apr; 55(4):428-440. PubMed ID: 31654131
[TBL] [Abstract][Full Text] [Related]
10. Liver Stiffness Measurement by Using Transient Elastography in Bangladeshi Patients with Type 2 Diabetes Mellitus and Ultrasonography-Diagnosed Nonalcoholic Fatty Liver Disease.
Alam MS; Kamrul-Hasan ABM; Kalam ST; Rahman SMM; Hoque MI; Islam MB; Paul AK
Diabetes Metab Syndr Obes; 2021; 14():3089-3096. PubMed ID: 34262313
[TBL] [Abstract][Full Text] [Related]
11. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
[TBL] [Abstract][Full Text] [Related]
12. Relationship between nonalcoholic fatty liver disease and hyperandrogenemia in adolescents with polycystic ovary syndrome.
Kara O; Arsoy HA; Keskin M
Clin Exp Pediatr; 2023 Sep; 66(9):395-402. PubMed ID: 37321582
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
[TBL] [Abstract][Full Text] [Related]
14. Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies.
Bellinato F; Gisondi P; Mantovani A; Girolomoni G; Targher G
J Endocrinol Invest; 2022 Jul; 45(7):1277-1288. PubMed ID: 35147926
[TBL] [Abstract][Full Text] [Related]
15. The Prevalence of Nonalcoholic Fatty Liver Disease and Related Metabolic Comorbidities Was Associated with Age at Onset of Moderate to Severe Plaque Psoriasis: A Cross-Sectional Study.
Xu X; Su L; Gao Y; Ding Y
PLoS One; 2017; 12(1):e0169952. PubMed ID: 28099469
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.
Gisondi P; Targher G; Zoppini G; Girolomoni G
J Hepatol; 2009 Oct; 51(4):758-64. PubMed ID: 19560226
[TBL] [Abstract][Full Text] [Related]
17. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study.
van der Voort EA; Koehler EM; Dowlatshahi EA; Hofman A; Stricker BH; Janssen HL; Schouten JN; Nijsten T
J Am Acad Dermatol; 2014 Mar; 70(3):517-24. PubMed ID: 24373781
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population.
Petta S; Di Marco V; Pipitone RM; Grimaudo S; Buscemi C; Craxì A; Buscemi S
Liver Int; 2018 Nov; 38(11):2060-2068. PubMed ID: 29577560
[TBL] [Abstract][Full Text] [Related]
19. Whether Screening for Non-alcoholic Fatty Liver Disease in Patients With Psoriasis Is Necessary: A Pilot Quality Improvement Project.
Torbator K; Poo S; Al-Rubaye T; Mapara L; Punjabi S; Al-Rubaye A; Alrubaiy L
Cureus; 2022 May; 14(5):e24714. PubMed ID: 35518363
[TBL] [Abstract][Full Text] [Related]
20. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
[No Abstract] [Full Text] [Related]
[Next] [New Search]